A systematic review and meta-analysis explored the relationship between androgen deprivation therapy and risk for heart failure in men with prostate cancer who were treated with ADT.

Researchers sought to determine postoperative outcomes of robot-assisted minimally invasive esophagectomy, LMIE, hybrid, and open surgical procedures for esophageal cancer.

The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...

Adjuvant chest wall irradiation should be omitted in most patients meeting the eligibility criteria for SUPREMO,” said Ian Kunkler, MB BChir.

Multidisciplinary collaborative approach to care is required for patients with hematological malignancies in pregnancy.

A population-based study revealed treatment patterns among patients starting chemotherapy as first-line therapy for ...

Erectile dysfunction (ED) and testosterone deficiency (TD) are more common among men with testicular cancer, a new study finds. In a study of US male veterans, investigators matched 1754 patients with ...

Olverembatinib demonstrated activity in patients with CP-CML who received first- or second-generation TKIs as first-line therapy.

A machine learning model can make accurate survival predictions for Merkel cell carcinoma (MCC), according to a study published online Jan. 8 in npj Digital Medicine. Noting there are no personalized ...

T-DXd outperformed physician’s choice of chemotherapy regardless of patients’ disease burden or time to progression on prior therapy.

The mortality rates were 15.5% for the ibrutinib group and 16.3% for the bendamustine group. Significant cardiovascular risks are associated with ibrutinib treatment in patients with chronic ...

The median duration of response was 6 months. Treatment with pembrolizumab and fulvestrant provided disease control in half of patients with estrogen receptor (ER)-positive, HER2-negative ...